The latest update is out from Rubicon Organics ( (TSE:ROMJ) ).
Rubicon Organics Inc. has announced its intention to acquire a 47,500 square foot indoor cultivation facility in Hope, British Columbia, from Medipharm Labs Inc. for $4.5 million. This acquisition is expected to significantly boost Rubicon’s production capacity, allowing the company to meet the growing demand for its premium cannabis products and strengthen its market position. The transaction is anticipated to close in the second quarter of 2025, with the first harvests expected the same year.
More about Rubicon Organics
Rubicon Organics Inc. is a global leader in premium organic cannabis products, operating through its subsidiary Rubicon Holdings Corp. The company focuses on profitability through its premium cannabis flower, product innovation, and brand management, including flagship brands like Simply Bare™ Organic, 1964 Supply Co™, and Wildflower™. Rubicon Organics ensures quality by cultivating, processing, branding, and selling organic certified cannabis from its facility in Delta, BC, Canada.
YTD Price Performance: -14.16%
Average Trading Volume: 28,070
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $15.65M
For detailed information about ROMJ stock, go to TipRanks’ Stock Analysis page.